Aurobindo Pharma completes ₹800 crore buyback of shares
pre-market1 source ↓written by the desknot a recommendation
- has successfully extinguished
- 54,23,728 equity shares
- ₹800 crore buyback programme
- was executed
- ₹1,475 per share
- period running
- 23 to 29 April 2026
Aurobindo Pharma has successfully extinguished 54,23,728 equity shares under its ₹800 crore buyback programme. The buyback was executed at ₹1,475 per share, with the tender offer period running from 23 to 29 April 2026. This move is expected to enhance shareholder value and improve earnings per share.
Not investment advice. For informational purposes only.